Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mitochondria-targeted partial inhibiton of complex I increase health and lifespan in aged male and female mice.

ABSTRACT: We performed next-generation RNA sequencing (RNA-seq) using brain and fat tissue from 26 months old vehicle and CP2-treated (wild-type) WT mice.

ORGANISM(S): Mus musculus

PROVIDER: GSE200921 | GEO | 2022/07/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Mitochondria-targeted partial inhibiton of complex I increase health and lifespan in mice.

Project description:We performed next-generation RNA sequencing (RNA-seq) using brain tissue from 23 months old vehicle and CP2-treated non-transgenic (NTG) and Young (3 months old) WT mice. By comparing transcriptomic data of vehicle and CP2-treated NTG_Old mice, we found processes affected by CP2 such as genes involved in regulation of circadian rhythm, immune system, oxidant detoxifications. In comparison to Young mice, CP2 treatment in NTG_Old mice downregulated the expression of gene sets involved in regulation of oxidative stress and lipid metabolism, which were both upregulated with old age in vehicle-treated NTG_Old mice.

2021-05-31 | GSE160996 | GEO

Mitochondria-targeted partial inhibiton of complex I increase health and lifespan in aged male and female mice.

Project description:Mitochondria-targeted partial inhibiton of complex I increase health and lifespan in aged male and female mice.

| PRJNA827339 | ENA

Mitochondria-targeted partial inhibiton of complex I increase health and lifespan in mice.

Project description:Mitochondria-targeted partial inhibiton of complex I increase health and lifespan in mice.

| PRJNA675089 | ENA

Ndufs4-knockout mouse with mitochondria complex I inhibitor treatment

Project description:Glucose hypometabolism is one of the major characteristics of Alzheimer's disease (AD). The energy deficiency in AD brain has been at least partially attributed to accelerated mitochondrial dysfunction than normal aging. In earlier publications, we have shown that small molecule mitochondrial complex I inhibitor CP2 facilitated mitochondrial regeneration and rescued mitochondrial deficiency in familial AD mice model APP-PS1. Here in this study, we investigated whether a typical mitochondrial deficiency mouse model could recapitulate molecular expression signatures of AD brain and whether CP2 was able to rescue the AD brain phenotype. Ndufs4 is one of the regulatory subunits of mitochondria complex I. Knockout of Ndufs4 resulted in complex I assembly failure and approximately half mitochondrial function loss. Ndufs4-knockout mice are viable but are short in lifespan (up to about 90 days). This model has been previously used to study Leigh syndrome, a heritable mitochondrial deficiency disease. In this dataset, we performed RNAseq on brains of CP2 treated Ndufs4-knockout mice and examined the expression changes upon CP2 treatment.

2023-12-01 | GSE242286 | GEO